Liu, Jing <br/><br/>
Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.  [electronic resource] 

 -  Biochemical pharmacology  Jun 2014 
 - 477-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2014.04.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--antagonists & inhibitors<br/>Autophagy--drug effects<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cytokines--antagonists & inhibitors<br/>Forkhead Box Protein O1<br/>Forkhead Transcription Factors--agonists<br/>G2 Phase--drug effects<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Mice<br/>Mice, Nude<br/>Neoplasm Proteins--agonists<br/>Neoplastic Stem Cells--drug effects<br/>Nerve Tissue Proteins--agonists<br/>Neurons--drug effects<br/>Phosphatidylinositol 3-Kinase--chemistry<br/>RNA Interference<br/>RNA-Binding Proteins--antagonists & inhibitors<br/>Random Allocation<br/>Recombinant Proteins--pharmacology<br/>Second Messenger Systems--drug effects<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays